Mankind Pharma Limited

MANKIND

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Sept 20263,145

    Quarter₹ croreYoY
    Jun 20242,403+4.5%
    Sept 20242,530+3.1%
    Dec 20242,397+1.6%
    Jun 20252,541+5.7%
    Sept 20252,609+3.1%
    Dec 20252,633+9.9%
    Mar 20262,582—
    Jun 20262,964+16.6%
    Sept 20263,145+20.6%
  • ₹ crore

    Sept 202659

    Quarter₹ crore
    Jun 202495
    Sept 2024106
    Dec 202470
    Jun 202564
    Sept 202578
    Dec 202557
    Mar 2026127
    Jun 202634
    Sept 202659
  • ₹ crore

    Sept 20263,204

    Quarter₹ crore
    Jun 20242,498
    Sept 20242,636
    Dec 20242,466
    Jun 20252,606
    Sept 20252,686
    Dec 20252,689
    Mar 20262,709
    Jun 20262,998
    Sept 20263,204
  • Cost structure
  • ₹ crore

    Sept 2026718

    Quarter₹ crore
    Jun 2024522
    Sept 2024526
    Dec 2024522
    Jun 2025585
    Sept 2025600
    Dec 2025617
    Mar 2026551
    Jun 2026684
    Sept 2026718
  • ₹ crore

    Sept 20262,420

    Quarter₹ crore
    Jun 20241,921
    Sept 20241,865
    Dec 20241,942
    Jun 20252,112
    Sept 20252,162
    Dec 20252,100
    Mar 20261,898
    Jun 20262,241
    Sept 20262,420
  • Exceptional items and tax
  • ₹ crore

    Sept 2026784

    Quarter₹ crore
    Jun 2024577
    Sept 2024770
    Dec 2024524
    Jun 2025494
    Sept 2025525
    Dec 2025505
    Mar 2026788
    Jun 2026757
    Sept 2026784
  • ₹ crore

    Sept 2026202

    Quarter₹ crore
    Jun 202493
    Sept 2024168
    Dec 2024108
    Jun 202581
    Sept 202566
    Dec 202556
    Mar 202674
    Jun 2026198
    Sept 2026202
  • Profit
  • ₹ crore

    Sept 2026582

    Quarter₹ croreYoY
    Jun 2024513+25.5%
    Sept 2024634+34.2%
    Dec 2024416-14.5%
    Jun 2025413-19.6%
    Sept 2025459-27.7%
    Dec 2025449+7.9%
    Mar 2026714—
    Jun 2026558+35.3%
    Sept 2026582+26.8%
  • Per share
  • ₹ per share

    Sept 202614.09

    Quarter₹ per share
    Jun 202412.82
    Sept 202415.84
    Dec 202410.35
    Jun 202510.00
    Sept 202511.12
    Dec 202510.89
    Mar 202617.29
    Jun 202613.53
    Sept 202614.09
  • Leverage
  • Debt to equity

    times

    Sept 20260.00x

    Quartertimes
    Jun 2024—
    Sept 2024—
    Dec 20240.01x
    Jun 20250.00x
    Sept 20250.00x
    Dec 20250.00x
    Mar 20260.00x
    Jun 20260.00x
    Sept 20260.00x
₹ croreJun 2024Sept 2024Dec 2024Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Income
2,4032,5302,3972,5412,6092,6332,5822,9643,145
Revenue YoY+4.5%+3.1%+1.6%+5.7%+3.1%+9.9%—+16.6%+20.6%
95106706478571273459
2,4982,6362,4662,6062,6862,6892,7092,9983,204
Cost structure
522526522585600617551684718
1,9211,8651,9422,1122,1622,1001,8982,2412,420
Exceptional items and tax
577770524494525505788757784
9316810881665674198202
Profit
513634416413459449714558582
Net profit YoY+25.5%+34.2%-14.5%-19.6%-27.7%+7.9%—+35.3%+26.8%
Per share
12.8215.8410.3510.0011.1210.8917.2913.5314.09
Leverage
Debt to equity——0.01x0.00x0.00x0.00x0.00x0.00x0.00x

Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.